The authors of this study, which intended to analyze how different oxidate serum proteins vary between SLE and controls, suggested that ApoC3 could be a biomarker in the subset of patients with lupus nephritis [11]. The gene discussed is APOC3; the disease is systemic lupus erythematosus.